Health Canada Approves Ocrevus for Pediatric Multiple Sclerosis
Health Canada approved the intravenous formulation of Ocrevus for treating pediatric relapsing-remitting multiple sclerosis.
Health Canada approved the intravenous formulation of Ocrevus for treating pediatric relapsing-remitting multiple sclerosis.